These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 15158966)

  • 1. Gel and solid matrix systems for the controlled delivery of drug carrier-associated nucleic acids.
    Fattal E; De Rosa G; Bochot A
    Int J Pharm; 2004 Jun; 277(1-2):25-30. PubMed ID: 15158966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravitreal delivery of oligonucleotides by sterically stabilized liposomes.
    Bochot A; Fattal E; Boutet V; Deverre JR; Jeanny JC; Chacun H; Couvreur P
    Invest Ophthalmol Vis Sci; 2002 Jan; 43(1):253-9. PubMed ID: 11773039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biodegradable microparticles for the controlled delivery of oligonucleotides.
    De Rosa G; Quaglia F; La Rotonda M; Besnard M; Fattal E
    Int J Pharm; 2002 Aug; 242(1-2):225-8. PubMed ID: 12176251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poly(lactide-co-glycolide) microspheres for the controlled release of oligonucleotide/polyethylenimine complexes.
    De Rosa G; Quaglia F; La Rotonda MI; Appel M; Alphandary H; Fattal E
    J Pharm Sci; 2002 Mar; 91(3):790-9. PubMed ID: 11920765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a sustained-release biodegradable polymer delivery system for site-specific delivery of oligonucleotides: characterization of P(LA-GA) copolymer microspheres in vitro.
    Lewis KJ; Irwin WJ; Akhtar S
    J Drug Target; 1998; 5(4):291-302. PubMed ID: 9713978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term release and improved intracellular penetration of oligonucleotide-polyethylenimine complexes entrapped in biodegradable microspheres.
    De Rosa G; Quaglia F; Bochot A; Ungaro F; Fattal E
    Biomacromolecules; 2003; 4(3):529-36. PubMed ID: 12741766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the ocular distribution of a model oligonucleotide after topical instillation in rabbits of conventional and new dosage forms.
    Bochot A; Mashhour B; Puisieux F; Couvreur P; Fattal E
    J Drug Target; 1998; 6(4):309-13. PubMed ID: 9894698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustained release of nanosized complexes of polyethylenimine and anti-TGF-beta 2 oligonucleotide improves the outcome of glaucoma surgery.
    Gomes dos Santos AL; Bochot A; Doyle A; Tsapis N; Siepmann J; Siepmann F; Schmaler J; Besnard M; Behar-Cohen F; Fattal E
    J Control Release; 2006 May; 112(3):369-81. PubMed ID: 16644054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liposomes dispersed within a thermosensitive gel: a new dosage form for ocular delivery of oligonucleotides.
    Bochot A; Fattal E; Gulik A; Couarraze G; Couvreur P
    Pharm Res; 1998 Sep; 15(9):1364-9. PubMed ID: 9755886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The use of liposomes as intravitreal drug delivery system].
    Bejjani RA; Jeanny JC; Bochot A; Behar-Cohen F
    J Fr Ophtalmol; 2003 Nov; 26(9):981-5. PubMed ID: 14631286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oligonucleotide delivery to tumours using macromolecular carriers.
    Dass CR
    Biotechnol Appl Biochem; 2004 Oct; 40(Pt 2):113-22. PubMed ID: 15070400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An antisense oligonucleotide carrier based on amino silica nanoparticles for antisense inhibition of cancer cells.
    Peng J; He X; Wang K; Tan W; Li H; Xing X; Wang Y
    Nanomedicine; 2006 Jun; 2(2):113-20. PubMed ID: 17292123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opsonized erythrocyte ghosts for liver-targeted delivery of antisense oligodeoxynucleotides.
    Kim SH; Kim EJ; Hou JH; Kim JM; Choi HG; Shim CK; Oh YK
    Biomaterials; 2009 Feb; 30(5):959-67. PubMed ID: 19027156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Applications of thermo-reversible pluronic F-127 gels in pharmaceutical formulations.
    Escobar-Chávez JJ; López-Cervantes M; Naïk A; Kalia YN; Quintanar-Guerrero D; Ganem-Quintanar A
    J Pharm Pharm Sci; 2006; 9(3):339-58. PubMed ID: 17207417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced oligonucleotide delivery to mouse retinal cells using iontophoresis.
    Andrieu-Soler C; Doat M; Halhal M; Keller N; Jonet L; BenEzra D; Behar-Cohen F
    Mol Vis; 2006 Sep; 12():1098-107. PubMed ID: 17093395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liposomal drugs dispersed in hydrogels. Effect of liposome, drug and gel properties on drug release kinetics.
    Mourtas S; Fotopoulou S; Duraj S; Sfika V; Tsakiroglou C; Antimisiaris SG
    Colloids Surf B Biointerfaces; 2007 Apr; 55(2):212-21. PubMed ID: 17223020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of targeted delivery systems for nucleic acid drugs.
    Mahato RI; Takakura Y; Hashida M
    J Drug Target; 1997; 4(6):337-57. PubMed ID: 9239575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biodegradable chitosan scaffolds containing microspheres as carriers for controlled transforming growth factor-beta1 delivery for cartilage tissue engineering.
    Cai DZ; Zeng C; Quan DP; Bu LS; Wang K; Lu HD; Li XF
    Chin Med J (Engl); 2007 Feb; 120(3):197-203. PubMed ID: 17355821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and characterization of PLGA microspheres containing a staphylokinase variant (K35R).
    He JT; Tao XM; Mo W; Song HY
    Yao Xue Xue Bao; 2006 Jan; 41(1):12-8. PubMed ID: 16683521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cationic microparticles consisting of poly(lactide-co-glycolide) and polyethylenimine as carriers systems for parental DNA vaccination.
    Oster CG; Kim N; Grode L; Barbu-Tudoran L; Schaper AK; Kaufmann SH; Kissel T
    J Control Release; 2005 May; 104(2):359-77. PubMed ID: 15907586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.